» Articles » PMID: 9244304

A Human Endogenous Retroviral Superantigen As Candidate Autoimmune Gene in Type I Diabetes

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 1997 Jul 25
PMID 9244304
Citations 97
Authors
Affiliations
Soon will be listed here.
Abstract

Microbial superantigens (SAGs) have been implicated in the pathogenesis of human autoimmune diseases. Preferential expansion of the Vveta7 T cell receptor positive T cell subset in patients suffering from acute-onset type I diabetes has indicated the presence of a surface membrane-bound SAG. Here, we have isolated a novel mouse mammary tumor virus-related human endogenous retrovirus. We further show that the N-terminal moiety of the envelope gene encodes an MHC class II-dependent SAG. We propose that expression of this SAG, induced in extrapancreatic and professional antigen-presenting cells, leads to beta-cell destruction via the systemic activation of autoreactive T cells. The SAG encoded by this novel retrovirus thus constitutes a candidate autoimmune gene in type I diabetes.

Citing Articles

Human Endogenous Retroviruses Expression in Autoimmunity.

Viret C, Bynoe M Yale J Biol Med. 2024; 97(4):521-528.

PMID: 39703611 PMC: 11650914. DOI: 10.59249/OIKF8301.


Antibodies against endogenous retroviruses.

Chisca M, Larouche J, Xing Q, Kassiotis G Immunol Rev. 2024; 328(1):300-313.

PMID: 39152687 PMC: 11659944. DOI: 10.1111/imr.13378.


Species-Specific Transcription Factors Associated with Long Terminal Repeat Promoters of Endogenous Retroviruses: A Comprehensive Review.

Hossain M, Nyame P, Monde K Biomolecules. 2024; 14(3).

PMID: 38540701 PMC: 10968565. DOI: 10.3390/biom14030280.


Recent Advances in Assessing the Clinical Implications of Epstein-Barr Virus Infection and Their Application to the Diagnosis and Treatment of Nasopharyngeal Carcinoma.

Yoshizaki T, Kondo S, Dochi H, Kobayashi E, Mizokami H, Komura S Microorganisms. 2024; 12(1).

PMID: 38276183 PMC: 10820804. DOI: 10.3390/microorganisms12010014.


Blocking Superantigen-Mediated Diseases: Challenges and Future Trends.

Wang P, Fredj Z, Zhang H, Rong G, Bian S, Sawan M J Immunol Res. 2024; 2024:2313062.

PMID: 38268531 PMC: 10807946. DOI: 10.1155/2024/2313062.